Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
Pei‐Chien Tsai, Hsing‐Tao Kuo, Chao‐Hung Hung, Kuo‐Chih Tseng, Hsueh‐Chou Lai, Cheng-Yuan Peng, Jing‐Houng Wang, Jyh-Jou Chen, Pei‐Lun Lee, Rong‐Nan Chien, Chi‐Chieh Yang, Gin‐Ho Lo, Jia‐Horng Kao, Chun‐Jen Liu, Chen‐Hua Liu, Sheng‐Lei Yan, Ming‐Jong Bair, Chun‐Yen Lin, Wei‐Wen Su, Cheng‐Hsin Chu, Chih-Jen Chen, Shui‐Yi Tung, Chi‐Ming Tai, Chih‐Wen Lin, Gin‐Ho Lo, Pin‐Nan Cheng, Yen‐Cheng Chiu, Chia‐Chi Wang, Jin‐Shiung Cheng, Wei‐Lun Tsai, Han‐Chieh Lin, Yi‐Hsiang Huang, Ming‐Lun Yeh, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chung, Chi-Yi Chen, Ming‐Lung Yu, Chi-Yi Chen, Ming‐Lung Yu
Topics & Concepts
Hepatocellular carcinomaMedicineMetforminIncidence (geometry)Chronic hepatitisInternal medicineDiabetes mellitusAntiviral therapyGastroenterologyHepatitis COncologyVirologyEndocrinologyVirusPhysicsOpticsMetabolism, Diabetes, and CancerHepatitis C virus researchLiver Disease Diagnosis and Treatment